INS and diabetes mellitus: This is an important and growing sub-population as primary care clinicians are challenged to up-titrate medication, seek better control of diabetes symptoms and HbA1c, and to judge the overall risks and benefits, the alternatives and the optimal timing of commencement of insulin therapy.